Skip to content

Clinical trials

Atherosclerosis trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: Bulgaria Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20111
20121
20181
20211
20224
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
AstraZeneca3
GlaxoSmithKline3
CSL Behring2
Novartis Pharmaceuticals2
Ionis Pharmaceuticals, Inc.1
NewAmsterdam Pharma1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis16
Cardiovascular Diseases6
Heart Diseases3
Acute Coronary Syndrome2
Coronary Artery Disease2
Coronary Disease2
Myocardial Infarction2
Peripheral Arterial Disease2
Stroke2
Atrial Fibrillation1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.